triamcinolone acetonide has been researched along with Retrolental Fibroplasia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, GJ; Choi, WS; Chung, IY; Kim, YH; Park, JM; Seo, SW; Yoo, JM | 1 |
| Choi, WS; Chung, IY; Kim, YH; Park, YJ; Yoo, JM | 1 |
| Kalpana, N; Narendran, V; Shah, PK | 1 |
| Azuma, N; Hiraoka, M; Kobayashi, Y; Nishina, S; Yokoi, T | 1 |
| May, CA | 1 |
| Hammes, HP; Jonas, JB; Sauder, G; Schubert, U; Spandau, UH | 1 |
| Chan-Kai, B; Fortun, JA; Holz, ER; Lakhanpal, RR | 1 |
| Geisen, P; Hartnett, ME; Martiniuk, DJ; McColm, JR; Peterson, LJ; Saito, Y | 1 |
| Akkoyun, I; Akova, YA; Haberal, N; Kahraman, B; Oto, S; Yilmaz, G | 1 |
| Hammes, HP; Jonas, JB; Spandau, UH; Vom Hagen, F | 1 |
10 other study(ies) available for triamcinolone acetonide and Retrolental Fibroplasia
| Article | Year |
|---|---|
Protective effects of triamcinolone acetonide upon the upregulation and phosphorylation of GAP 43 in an animal model of retinopathy of prematurity.
Topics: Animals; Blotting, Western; Disease Models, Animal; Female; GAP-43 Protein; Gene Expression Regulation; Glucocorticoids; Humans; Hyperoxia; Immunohistochemistry; Infant, Newborn; Oxygen; Phosphorylation; Pregnancy; Rats; Rats, Sprague-Dawley; Retinopathy of Prematurity; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triamcinolone Acetonide; Up-Regulation | 2010 |
Treatment with triamcinolone acetonide prevents decreased retinal levels of decorin in a rat model of oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; Blotting, Western; Cell Death; Decorin; Disease Models, Animal; Extracellular Matrix Proteins; Female; Glucocorticoids; Humans; Hyperoxia; Immunohistochemistry; In Situ Nick-End Labeling; Infant, Newborn; Oxygen; Pregnancy; Proteoglycans; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Retinopathy of Prematurity; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triamcinolone Acetonide | 2010 |
Triamcinolone acetonide-assisted vitrectomy for stage 4 retinopathy of prematurity.
Topics: Follow-Up Studies; Gestational Age; Glucocorticoids; Humans; Infant, Newborn; Injections; Intraoperative Period; Retinopathy of Prematurity; Triamcinolone Acetonide; Vitrectomy | 2011 |
Fluorescein staining of the vitreous during vitrectomy for retinopathy of prematurity.
Topics: Birth Weight; Fluorescein; Fluorescein Angiography; Gestational Age; Humans; Infant; Infant, Newborn; Injections, Intravenous; Intravitreal Injections; Retinal Detachment; Retinopathy of Prematurity; Staining and Labeling; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2011 |
The influence of triamcinolone on endostatin-like proteins in oxygen-induced retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Endostatins; Glucocorticoids; Humans; Infant, Newborn; Intravitreal Injections; Mice; Oxygen; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Triamcinolone Acetonide | 2012 |
Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.
Topics: Animals; Animals, Newborn; Cattle; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Fibroblast Growth Factor 2; Glucocorticoids; Humans; Infant, Newborn; Mice; Mice, Inbred C57BL; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Triamcinolone Acetonide | 2005 |
Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity.
Topics: Birth Weight; Combined Modality Therapy; Female; Gestational Age; Glucocorticoids; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Injections; Lens, Crystalline; Male; Retinal Detachment; Retinal Neovascularization; Retinopathy of Prematurity; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; Apoptosis; Capillaries; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Glucocorticoids; Humans; Infant, Newborn; Injections; Oxygen; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2006 |
Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model.
Topics: Animals; Animals, Newborn; Cell Count; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; Glucocorticoids; Humans; Infant, Newborn; Injections; Mice; Mice, Inbred C57BL; Oxygen; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Triamcinolone Acetonide; Vitreous Body | 2007 |
Effect of intravitreal triamcinolone acetonide on retinal apoptosis in experimental retinal neovascularization.
Topics: Animals; Animals, Newborn; Apoptosis; Disease Models, Animal; Glucocorticoids; Humans; Infant, Newborn; Mice; Mice, Inbred C57BL; Oxygen; Retina; Retinal Neovascularization; Retinopathy of Prematurity; Triamcinolone Acetonide; Vitreous Body | 2008 |